Sen, Ethan S.
Dick, Andrew D.
Ramanan, Athimalaipet V.
Article History
First Online: 31 March 2015
Competing interests
: A.D.D. declares that he has served as a consultant for Abbvie, Genentech and Novartis, has received grants from Novartis, and is a co-investigator for the SYCAMORE trial of adalimumab in patients with JIA-associated uveitis, which is funded by Health Technology Assessment and Arthritis Research UK. A.V.R. declares that he has received honoraria or speaker's fees from Abbvie, Novartis, Pfizer, Roche, and Swedish Orphan Biovitrum Pharmaceuticals, and that he is co-chief investigator of the SYCAMORE trial. E.S.S. declares no competing interests.